Cold, Flu & Cough

What is the Common Cold?

The common cold, also known as rhinopharyngitis, is a type of respiratory tract infection caused by a virus.

Walking Pneumonia Versus Common Cold

Risk Factors and Walking Pneumonia Prevention

Influenza Infection in Animals

See more featured articles »

Walking Pneumonia Versus Common Cold

Does the 'Stomach Flu' Vaccine Prevent Type I Diabetes?

Latest Cold, Flu & Cough News and Research

European collaboration transforms immune cell data into cancer biomarkers

World Cancer Day, marked on 4 February, is an international day dedicated to raising awareness of cancer, and to encouraging its prevention, detection and treatment.

6 Feb 2026

New DNA-based vaccine scaffolds boost targeted immune responses to HIV

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and antibodies. In most vaccines, HIV proteins are attached to a larger protein scaffolding that mimics a virus.

6 Feb 2026

Inhibiting PTP1B protein improves memory in Alzheimer’s disease models

Alzheimer's disease is often measured in statistics: millions affected worldwide, cases rising sharply, costs climbing into the trillions.

5 Feb 2026

Artificial lung keeps patient alive after lung removal

Researchers evaluate the effectiveness of a novel extracorporeal total artificial lung system to enable bilateral pneumonectomy in patients with severe ARDS.

5 Feb 2026

Influenza D virus and canine coronavirus pose human risks

Two emerging pathogens with animal origins - influenza D virus and canine coronavirus - have so far been quietly flying under the radar, but researchers warn conditions are ripe for the viruses to spread more widely among humans.

5 Feb 2026

Five mutation patterns shape how cancers evade immunity

Cancer cells carry thousands of mutations, but not all mutations are created equal. Some make tumors highly visible to the immune system, while others help cancers hide.

4 Feb 2026

Why did influenza fail to spread in a crowded indoor setting?

The EMIT-2 trial shows zero influenza transmission despite ideal conditions, suggesting a perfect storm is needed for the virus to spread effectively.

4 Feb 2026

Australian researchers develop a new way to target deadly, drug-resistant bacteria

Australian researchers have developed a powerful new way to target deadly, drug-resistant bacteria by designing antibodies that recognize a sugar found only on bacterial cells – an advance that could underpin a new generation of immunotherapies for multidrug resistant hospital-acquired infections.

4 Feb 2026

Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment

A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study a delayed release preparation, or wafer, of an immunostimulatory molecule to stimulate the central nervous system (CNS) immune system after surgery to remove glioblastoma, a form of primary brain cancer.

3 Feb 2026

Poll: Many adults over 50 skip flu and COVID vaccines

This winter's brutal flu season isn't over, and COVID-19 cases have risen recently too. But a new poll taken in recent weeks shows that vaccination against both viruses lags among people 50 and over, and the national survey reveals key reasons why.

3 Feb 2026

Six years after COVID-19: Lessons learned and pandemic preparedness

Six years ago, the Director-General of the World Health Organization sounded the highest global alarm available under international law at the time, declaring the outbreak of a new coronavirus disease (later known as COVID-19) a Public Health Emergency of International Concern (PHEIC).

3 Feb 2026

Bacteria repurpose viral injection systems to target diverse cells

New study shows how bacteria adapted a virus-derived injection system to recognize and attach to many different types of cells.

2 Feb 2026

Most commercially insured patients live with chronic conditions

The majority (57.5 percent) of commercially insured patients had at least one chronic condition in 2024. The average allowed amount for a patient with no chronic conditions was $1,590, while the average allowed amount for a patient with one chronic condition was nearly double ($3,039).

2 Feb 2026

Clinical trial launched to test experimental intranasal spray against respiratory viruses

Last year, at least one million people in the U.S. were hospitalized for respiratory virus illnesses like the flu or COVID-19, according to the Centers for Disease Control and Prevention.

2 Feb 2026

Overlooked animal viruses slipping past global disease surveillance

The study on Influenza D and Canine Coronavirus HuPn-2018 underscores urgent needs for targeted surveillance and diagnostics in infectious disease research.

2 Feb 2026

How the CDC prepares influenza vaccines for pandemics

CDC scientists outline the comprehensive methodology involved in the development of influenza candidate vaccine viruses.

2 Feb 2026

Chlamydia pneumoniae found in the eye may aggravate Alzheimer’s disease

Chlamydia pneumoniae—a common bacterium that causes pneumonia and sinus infections—can linger in the eye and brain for years and may aggravate Alzheimer’s disease, according to a study from Cedars-Sinai.

1 Feb 2026

Nasal spray vaccine prevents infection from highly pathogenic H5N1 virus

Researchers at WashU Medicine have developed a nasal vaccine against the highly pathogenic H5N1 avian influenza virus, or bird flu, which has jumped from wild birds to livestock to humans.

30 Jan 2026

Early TB treatment before sepsis diagnosis could save countless lives

Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are diagnosed with TB – could save countless lives, the researchers say.

30 Jan 2026